Question Period Notes
About this information
In accordance with the Access to Information Act, the government proactively publishes the package of question period notes that were prepared by a government institution for the minister and that were in use on the last sitting day in June and December.
The question period notes may be partially or fully redacted in accordance with the legislation; for example, if the notes contain information related to national security or personal information. (Learn more about exemptions and exclusions.)
If you find a question period note of interest, you may make an access to information request in order to obtain it.
Q1 – Why are there differences between Canada and the United States in the measures to mitigate bovine spongiform encephalopathy risk? Q2 – How does the detection of atypical bovine spongiform encephalopathy in Canada affect the risk status designation? Q3 – How does Canada’s negligible risk status for bovine spongiform encephalopathy affect trade? Q4 – How will recent funding announced in Budget 2024 support the Government in addressing the impact of BSE?
Q1 – What measures has the Government of Canada already put in place to address the threat that the global spread of African swine fever poses to Canada’s swine industry? Q2 – (AAFC) How does the launch of Agriculture and Agri-Food Canada’s African Swine Fever Industry Preparedness Program help to mitigate the risks and impacts of the disease? Q3 – How has the CFIA tested or validated its preparedness efforts?
Q1 – What is the Government of Canada policy on vaccination for foot and mouth disease? Q2 – How is Canada working to secure sufficient doses of vaccines to protect Canada’s livestock industry against a large-scale foot and mouth disease outbreak?
Q1 – What is the Government doing to prevent the introduction and spread of dog rabies in Canada? Q2 – Why has the Government implemented a measure to prohibit the entry of commercial dogs from countries at high-risk for dog rabies? Q3 – Why does the Canadian Food Inspection Agency update the list of countries at high-risk for dog rabies? / Why are countries being included/removed from the list? Q4 – What is the Government doing for people fleeing war zones with their pet dogs? Q5 – What is the Government’s response to petitions to ban puppy mills and prevent puppy mill imports?
Q1 – How will the Canadian Food Inspection Agency implement the Pan-Canadian Action Plan on antimicrobial resistance?
Q1 – What is the Canadian Food Inspection Agency doing to protect animals and the food chain from contaminants in biosolids? Q2 – Has the Government of Canada formulated a risk management plan to mitigate risks posed by perfluoroalkyl and polyfluoroalkyl substances (PFAS)? Q3 – How are biosolids imported from the United States to Quebec regulated? Q4 - Why is the Government of Canada not applying standards as strict as those proposed by the Government of Quebec?
Q1 – What is the Government’s response to chronic wasting disease in Canada? Q2 – Does chronic wasting disease pose a risk to human health or food safety? Q3 - What is the government’s approach to reducing the trade impact of chronic wasting disease?
Q1 – How is the Canadian Food Inspection Agency helping to remove interprovincial trade barriers in Canada? Q2 – How are Federal and Provincial partners supporting the interprovincial food trade pilot in Lloydminster? Q3 – How will the Canadian Food Inspection Agency ensure food safety during the provincial pilot? Q4 – Why just Lloydminster? Why won’t the amendment apply to other cities near provincial borders?
Q1 – What is the Government of Canada doing to support modern plant breeding techniques and keep pace with technology in plant breeding? Q2 – Why was a guidance update needed? Q3– How is the Government working with industry on plant breeding innovation? Q4 – Was the Government’s consultation on plant breeding innovation too narrow, or compromised by outside influence? Q5 – How does the Government ensure the integrity of the organic sector? Q6–How do plant breeders know if a pre-market safety assessment is needed?
Q7 – How does Canada’s updated gene editing guidance compare with other countries?
Q1 – What action is the Government of Canada taking regarding the end of operations at some Olymel plants in Quebec? Q2 – What programs are available to help producers? Q3 - Did the decision to close the Olymel plants come as the result of regulatory burden or requirements?